More than 2,000 eminent scientists, innovators, and researchers -- as well as industry analysts representing a broad range of disciplines and companies from around the world -- will converge in Phoenix to network, discover and explore. The five-day conference will include feature presentations, short courses, and workshops emphasizing the growing integration of the sciences and their effect on drug research and development. The scientific program is will explore core topics in lead discovery; assays and automation; critical reagents and more.